Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,199.32
(
-0.61%
)
News Focus
News Focus
Post# of 824139
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biosectinvestor

Send PM Follow Ignore
Followers 200
Posts 25597
Boards Moderated 0
Alias Born 04/03/2010

biosectinvestor

Re: danielboog2 post# 501123

Thursday, 08/04/2022 12:25:20 PM

Thursday, August 04, 2022 12:25:20 PM

Post# of 824139
They presented stellar trial data, they have outperformed many other investments over 5 and 2 years measure and YTD are flat while much of the market is severely down.

I would take their trial results over the 400+ trials that have failed in GBM and their improvement in results over any drug announced in the last 20-30 years overall for GBM, well, really ever.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169583224
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News